51. How can aging research impact public health in the future?

Aging research already informs risk stratification and prevention, but its direct impact on clinical care and public health remains limited compared with its potential. Near term: risk stratification, early detection of age-related conditions (e.g., using organ-specific clocks), personalized interventions, surgical and oncology fitness, and amelioration of cardio-metabolic decline. Mid-term: menopause/ovarian aging care, neurodegeneration targeting, prevention guided by biomarkers. Long-term: radically slowing aging with approaches that do not yet exist but can be inferred from studies, such as cross-species, replacement and rejuvenation strategies. These approaches would target the aging process itself, not only age-related diseases.